USD0.000åå ŽååŒÂ  (ET)
2.93MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKey æ ªåŒã¹ã³ã¢
å¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
忥ä»ç€Ÿæ¯èŒ
TradingKeyã®Bone Biologics Corpã®æ ªåŒã¹ã³ã¢
é貚: USD æŽæ°æå»: 2026-02-02 äž»èŠã€ã³ãµã€ã
Bone Biologics Corpã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã®é äœã¯393äž240äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ãããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯22.25ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯è¯å¥œã§ããã¡ã³ãã¡ã³ã¿ã«ãºãåªããŠããŸãããããã¯ãã«ã«ã¯çŸåšã®ãã¬ã³ããè£ä»ãããã®ã§ã¯ãããŸãããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Bone Biologics Corpã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Bone Biologics Corpã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
財åå¥å
šæ§
é貚: USD æŽæ°æå»: 2026-02-02 Bone Biologics Corpã®çŸåšã®è²¡åã¹ã³ã¢ã¯7.04ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã«ãããã©ã³ãã³ã°ã¯393瀟äž165äœã§ãã ãã®è²¡åç¶æ³ã¯å
調ã§ãã ãŸããäºæ¥å¹çã¯äœãã§ãã
é¢é£èšäº
çŸéããã³çŸéåçç©
ç·è³ç£
è² åµåèš
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ç·å£²äžé«
å¶æ¥å©ç
ç·è³ç£
販売費 & äžè¬ç®¡çè²»

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
çšåŒåŸå©ç

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
å¶æ¥æŽ»åã«ãããã£ãã·ã¥ãããŒ
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
é¢é£èšäº
ããªãŒãã£ãã·ã¥ãããŒ

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Bone Biologics Corpã®äŒæ¥äŸ¡å€è©äŸ¡
é貚: USD æŽæ°æå»: 2026-02-02Bone Biologics Corpã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯7.22ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã¯393瀟äž150äœã§ãã çŸåšã®PERã¯-0.69ã§ãçŽè¿é«å€0.14ã-120.37%äžåããçŽè¿å®å€-3.00ã-336.65%äžåã£ãŠããŸãã
ããªã¥ãšãŒã·ã§ã³
PER
PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
PSR
PCFR
æ¥çå
é äœ 240/393

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-02-02Bone Biologics Corpã®åçäºæž¬ã¹ã³ã¢ã¯çŸåšå©çšã§ããŸããããªãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³åã¯8.04ã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯22.25ã§ãæé«ã¯22.25ãæäœã¯22.25ã§ãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã

ããŒã¿ãªã
財åäºæž¬

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
æ ªäŸ¡ã¢ã¡ã³ã¿ã
é貚: USD æŽæ°æå»: 2026-02-02Bone Biologics Corpã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯2.25ã§ããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã¯393瀟äž378äœã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·1.88ãšæ¯æç·1.38ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ææš
î°
î°
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ
ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ
å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
ææš
売ã(2)
äžç«(3)
è²·ã(0)
ç§»åå¹³å
売ã(6)
äžç«(0)
è²·ã(0)
æ©é¢æè³å®¶ã®ä¿¡é Œæ
é貚: USD æŽæ°æå»: 2026-02-02æ©é¢æè³å®¶ä¿ææ ª

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»åå
Geode Capital Management, L.L.C.
UBS Financial Services, Inc.
Tower Research Capital LLC
Citi Investment Research (US)
ãªã¹ã¯è©äŸ¡î°î°
é貚: USD æŽæ°æå»: 2026-02-02ç±³ãã«ææ°ã¯çŸåšäžç«ã®ç¶æ
ã«ããããã€ãªãã¯ãããžãŒ & å»çç ç©¶ã®å
é忥çã«äžç«çãªã®åœ±é¿ãåãŒããŠããŸãããã«ææ°ïŒDXYïŒã¯ããŠãŒããåãè±ãã³ããã«ãããã«ãã¹ãŠã§ãŒãã³ã»ã¯ããŒããã¹ã€ã¹ã»ãã©ã³ãå«ãäž»èŠé貚ãã¹ã±ããã«å¯Ÿããç±³ãã«ã®äŸ¡å€ã枬å®ãããã®ã§ãã Bone Biologics Corpã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯çŸåšå©çšã§ããŸããããªãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã®å¹³åã¯3.37ã§ãã å瀟ã®ããŒã¿å€ã¯0.75ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯äžèœå¹
ãéå®çãšãªãåŸåã瀺ããŠããŸãã
S&P 500ææ°ãšã®ããŒã¿å€
0.75
240æ¥éã®æå€§ãããŒããŠã³
+78.55%
240æ¥éã®ãã©ãã£ãªãã£
+221.13%
æ»ã
æ¥æ¬¡ãªã¿ãŒã³ïŒæå€§ïŒ
æ¥æ¬¡ãªã¿ãŒã³ïŒæå°ïŒ
ãªã¹ã¯è©äŸ¡
ãªã¿ãŒã³/ãããŒããŠã³æ¯ç
ãã©ãã£ãªãã£
å®çŸãã©ãã£ãªãã£
æšæºåãã¥ã«ãŒã¬ã³ãž
ããŠã³ãµã€ããªã¹ã¯èª¿æŽåŸãªã¿ãŒã³
æå€§æ¥æ¬¡äžæãã©ãã£ãªãã£
æå€§æ¥æ¬¡äžèœãã©ãã£ãªãã£
æµåæ§
売買å転çã®å€åå¹
ãã€ãªãã¯ãããžãŒ & å»çç ç©¶
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡

Viridian Therapeutics Inc
VRDN
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
財åå¥å
šæ§
ããªã¥ãšãŒã·ã§ã³
åçäºæž¬
æ ªäŸ¡ã¢ã¡ã³ã¿ã
æ©é¢æè³å®¶ã®ä¿¡é Œæ
ãªã¹ã¯è©äŸ¡
詳现ãèŠã